Literature DB >> 35881385

Whole Blood Dendritic Cell Cytokine Production Assay.

Tonia Woodberry1, Jessica Rita Loughland1,2, Gabriela Minigo3,4.   

Abstract

This protocol outlines a method for the timely detection of intracellular cytokines produced by activated dendritic cells (DC) in human whole blood. The quantification of cytokines is used to measure DC immune responsiveness, providing information on the breadth, strength, and DC subtypes responding spontaneously and to specific stimulation with toll-like receptor (TLR) ligands or parasite-infected erythrocytes. DC subsets, plasmacytoid DC, CD1c+ DC, CD141+ DC, and CD16+ DC, are examined in their natural environment of plasma and blood cells (erythrocytes, neutrophils, platelets, and leukocytes) enabling disease, medication, nutritional, and hematological effects on DC function to be examined in vaccine studies, ageing, health, and disease.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Blood dendritic cell antigen (BDCA); Dendritic cell subsets; Human assay; Intracellular cytokine production; Malaria; Parasite; Toll-like receptor; Whole blood

Mesh:

Substances:

Year:  2022        PMID: 35881385     DOI: 10.1007/978-1-0716-2189-9_53

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  Characterization of human blood dendritic cell subsets.

Authors:  Kelli P A MacDonald; David J Munster; Georgina J Clark; Andrzej Dzionek; Juergen Schmitz; Derek N J Hart
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

2.  Peripheral blood manipulation significantly affects the result of dendritic cell monitoring.

Authors:  Jeroen H Gerrits; Petros Athanassopoulos; Lenard M B Vaessen; Mariska Klepper; Willem Weimar; Nicole M van Besouw
Journal:  Transpl Immunol       Date:  2006-12-08       Impact factor: 1.708

Review 3.  Review of human DC subtypes.

Authors:  Xinsheng Ju; Georgina Clark; Derek N J Hart
Journal:  Methods Mol Biol       Date:  2010

4.  Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection.

Authors:  Jessica R Loughland; Gabriela Minigo; Julie Burel; Peta E Tipping; Kim A Piera; Fiona H Amante; Christian R Engwerda; Michael F Good; Denise L Doolan; Nicholas M Anstey; James S McCarthy; Tonia Woodberry
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

5.  Enumeration and phenotypic assessment of human plasmacytoid and myeloid dendritic cells in whole blood.

Authors:  Ferdousi Chowdhury; Peter Johnson; Anthony Peter Williams
Journal:  Cytometry A       Date:  2010-04       Impact factor: 4.355

Review 6.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

7.  A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes.

Authors:  Hong Zhang; Josh D Gregorio; Toru Iwahori; Xiangyue Zhang; Okmi Choi; Lorna L Tolentino; Tyler Prestwood; Yaron Carmi; Edgar G Engleman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

8.  CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.

Authors:  Toshimichi Matsui; John E Connolly; Mark Michnevitz; Damien Chaussabel; Chun-I Yu; Casey Glaser; Sasha Tindle; Marc Pypaert; Heidi Freitas; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 9.  Human dendritic cell subsets: an update.

Authors:  Matthew Collin; Venetia Bigley
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

10.  Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.

Authors:  Jessica R Loughland; Tonia Woodberry; Michelle J Boyle; Peta E Tipping; Kim A Piera; Fiona H Amante; Enny Kenangalem; Ric N Price; Christian R Engwerda; Nicholas M Anstey; James S McCarthy; Gabriela Minigo
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.